← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2017Last known activity
Dec 9, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06728839CollaboratorN/ADec 9, 2024
- NCT07299123CollaboratorPhase 1/Phase 2Aug 1, 2023
- NCT05159947CollaboratorPhase 3Dec 31, 2021
- NCT04850950CollaboratorPhase 4Apr 26, 2021
- NCT04475835CollaboratorN/AOct 31, 2020
- NCT03755869CollaboratorPhase 4Dec 31, 2018
- NCT02982668CollaboratorN/AJan 1, 2017
Details
- Last known activity
- Dec 9, 2024